Method development and validation of difference UV spectrophotometric estimation of lafutidine in bulk and pharmaceutical dosage form

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL. 4, 2012, Pages 284-287

  Dave, Vidhi S ^a   Patel, Mandev B ^a  

^a Shri AK Raval Charitable Trust   (India)

Author keywords

Difference spectrophotometric; Lafutidine

Indexed keywords

LAFUDAC; LAFUTIDINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG DETERMINATION; SENSITIVITY AND SPECIFICITY; TABLET FORMULATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84866340078     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. th Edn: Pharmaceutical press: London, p. 1269.
2. Kazuhirofukushima, Aoi Y, Kato S, Takeuchi K; "Gastro protective action of Lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins"; world J. of gastroenterology, 2006, 12(19):3031-3037.
3. Shimatani T, Inoue M, Kuroiwa T, Xu J, Nakamura M, Tazuma S, Ikawa K, Morikaw "Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans"; European J. of Pharmacology, 11 May 2011, Volume 658, Issues 2-3 P. 236-241.
4. Heng Z, et al., "Determination of Lafutidine in human plasma by HPLC-MS", the Chinese J. of pharmacology, 2008-01-023.
5. Xiang-lin Z, Yun-di Q, "Determination of Lafutidine in human serum by HPLC-FD method and study of pharmacokinetics": Chinese J. of hospital pharmacy; 2005-12.
6. Chen W, Liang Y, Hao Li, Xiong Y, Xiao-Dong Liu, Wang G, "Simple, sensitive and rapid LC-ESI-MS method" for the quantitation of Lafutidine in human plasma Application to pharmacokinetic studies, J. of Pharmaceutical and Biomedical Analysis, Volume 41, Issue 1, 11 April 2006: 256-60.
7. Yong Z, Mei C, Chun-jing Z, et al., "Determination of Lafutidine in serum with reverse high performance liquid chromatography", Journal of Pediatric Pharmacy; 2006-03.
8. Ying-ying S, Jing, Xian-chen HE; "Determination of residual organic solvent in Lafutidine by GC": west china J. of Pharmaceutical science-2005-04.
9. Ying-ying S, Jing S, Xian-chen HE, Xiu-ai HU, "Determination of related Substance in Lafutidine by RP-HPLC", The Chinese J. of Modern Applied Pharmacy: 2005-04.
10. Xing-fa Y, Peng H, "Determination of Lafutidine and its tablets by HPLC", Northwest Pharmaceutical J.; 2003-06.
11. Sumithra M., Shanmuga P., Sundaram, Srinivasulu K., " Analytical Method Development and Validation of LafSutidine in Tablet dosage form by RP-HPLC" International J. of ChemTech Research, Vol. 3, No.3, July-Sept 2011,1403-07.
12. Jadhav K, Dhamecha D, at el. "Application of UV spectrophotometric method for easy and rapid estimation of Lafutidine in bulk and pharmaceutical, formulation, " Pharm Methods 2011; 2: 264-7.
13. ICH Guideline Q2B, Validation of Analytical Procedures, Methodology, 1996, 1.
14. Kunti D., Raskapur, Mrunali M., " UV-spectrophotometric method development and validation for determination of azelnidipine in pharmaceutical dosage form", International J. of Pharmacy and Pharmaceutical Sciences, Vol 4, Issue 1, 2012.
15. Wamorkar V, manjunathSY., m. Mohan varma " Development and Validation of UV spectroscopic method for determination of Metoclopramide hydrochloride in bulk and tablet formulation" International J. of Pharmacy and Pharmaceutical Sciences, Vol 3, Issue 3, 2011.